| 000 | 01446 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513110850.0 | ||
| 264 | 0 | _c19970417 | |
| 008 | 199704s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/s0264-410x(96)00077-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCoombes, A G | |
| 245 | 0 | 0 |
_aSingle dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. _h[electronic resource] |
| 260 |
_bVaccine _cOct 1996 |
||
| 300 |
_a1429-38 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlum Compounds |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies _xblood |
| 650 | 0 | 4 | _aBiocompatible Materials |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 | _aLactic Acid |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicrospheres |
| 650 | 0 | 4 |
_aOvalbumin _xadministration & dosage |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aPolyglycolic Acid |
| 650 | 0 | 4 | _aPolylactic Acid-Polyglycolic Acid Copolymer |
| 650 | 0 | 4 | _aPolymers |
| 650 | 0 | 4 |
_aVaccines _xadministration & dosage |
| 700 | 1 | _aLavelle, E C | |
| 700 | 1 | _aJenkins, P G | |
| 700 | 1 | _aDavis, S S | |
| 773 | 0 |
_tVaccine _gvol. 14 _gno. 15 _gp. 1429-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0264-410x(96)00077-1 _zAvailable from publisher's website |
| 999 |
_c8985579 _d8985579 |
||